Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits.

Candida albicans strain diversity and fluconazole resistance were prospectively analyzed in oral strains from 29 adult human immunodeficiency virus (HIV)-positive patients followed for > 1 year who had five or more culture-positive clinic visits. Molecular typing consisted of genomic blots probed with the Ca3 repetitive element. Sixteen patients had one or more episodes of oropharyngeal candidiasis (OPC), 12 (75%) maintained the original genotype, whereas the remaining four patients had a succession of 2-3 genotypes. The original genotype, either alone or mixed with another strain or with non-C. albicans Candida spp., was recovered from oral lesions in 13 of 15 evaluable (86.7%) patients. C. dubliniensis was the infecting yeast in the remaining two patients. Different patterns of fluconazole resistance occurred in three OPC patients. One patient's infecting strain became less susceptible. A second patient was infected with a resistant genotype and a progressively more susceptible minor genotype variant. C. dubliniensis isolates from the third patient varied in susceptibility. Thirteen colonized patients who never developed OPC harbored a greater variety of C. albicans genotypes (2-6) than their infected counterparts (P = 0.35). OPC patients maintained their original endogenous C. albicans strains for prolonged periods, whether or not they demonstrated decreased in vitro susceptibility to fluconazole. The adaptation and maintenance of an endogenous C. albicans strain within its host may be linked to as yet uncharacterized factors.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  J. Ward,et al.  Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. , 1999, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[3]  J. Rex,et al.  Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  T. Lott,et al.  Rapid Identification of Candida Species with Species-Specific DNA Probes , 1998, Journal of Clinical Microbiology.

[5]  S. Sanche,et al.  Detection of Candida dubliniensis in Oropharyngeal Samples from Human Immunodeficiency Virus-Infected Patients in North America by Primary CHROMagar Candida Screening and Susceptibility Testing of Isolates , 1998, Journal of Clinical Microbiology.

[6]  R. Haubrich,et al.  Random Amplification of Polymorphic DNA and Microsatellite Genotyping of Pre- and Posttreatment Isolates ofCandida spp. from Human Immunodeficiency Virus-Infected Patients on Different Fluconazole Regimens , 1998, Journal of Clinical Microbiology.

[7]  S. Hammer,et al.  Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. , 1998, JAMA.

[8]  Kenji Tanaka,et al.  Repetitive sequences (RPSs) in the chromosomes of Candida albicans are sandwiched between two novel stretches, HOK and RB2, common to each chromosome. , 1998, Microbiology.

[9]  T. C. White,et al.  Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance , 1998, Clinical Microbiology Reviews.

[10]  E. Anaissie,et al.  Optimizing the Correlation between Results of Testing In Vitro and Therapeutic Outcome In Vivo for Fluconazole by Testing Critical Isolates in a Murine Model of Invasive Candidiasis , 1998, Antimicrobial Agents and Chemotherapy.

[11]  M. Pfaller,et al.  Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infection , 1997, Journal of clinical microbiology.

[12]  D. Soll,et al.  Most frequent scenario for recurrent Candida vaginitis is strain maintenance with "substrain shuffling": demonstration by sequential DNA fingerprinting with probes Ca3, C1, and CARE2 , 1996, Journal of clinical microbiology.

[13]  C. Kauffman,et al.  Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus , 1994, Antimicrobial Agents and Chemotherapy.

[14]  G. Reboux,et al.  Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype , 1994, Journal of clinical microbiology.

[15]  J. Perfect,et al.  Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1 , 1993, Antimicrobial Agents and Chemotherapy.

[16]  B. Dupont,et al.  Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole , 1993, Journal of clinical microbiology.

[17]  T. C. White,et al.  Characterization and partial nucleotide sequence of the DNA fingerprinting probe Ca3 of Candida albicans , 1993, Journal of clinical microbiology.

[18]  T. C. White,et al.  The identification and tracking of Candida albicans isolates from oral lesions in HIV-seropositive individuals. , 1992, Journal of acquired immune deficiency syndromes.

[19]  T. Lott,et al.  Isolation, characterization, and sequencing of Candida albicans repetitive element 2. , 1992, Gene.

[20]  D. Soll,et al.  Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting , 1992, Journal of clinical microbiology.

[21]  D. Soll,et al.  Telomeric and dispersed repeat sequences in Candida yeasts and their use in strain identification , 1991, Journal of bacteriology.

[22]  D. Soll,et al.  High-frequency switching in Candida strains isolated from vaginitis patients , 1987, Journal of clinical microbiology.

[23]  E. Bruck,et al.  National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.

[24]  S. Hume,et al.  A longitudinal study of the change in resistance patterns and genetic relationship of oral Candida albicans from HIV-infected patients. , 1995, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[25]  J. Wingard,et al.  Importance of Candida species other than C. albicans as pathogens in oncology patients. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  M. Ashburner A Laboratory manual , 1989 .